CorMedix (CRMD) Total Current Liabilities (2010 - 2026)

CorMedix has reported Total Current Liabilities for 15 years, with the latest figure at $174.3 million in Q4 2025.

• Quarterly Total Current Liabilities rose 414.98% year-over-year to $174.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $174.3 million (up 414.98% YoY) and the FY2025 annual result came in at $174.3 million, up 414.98% from the prior year.
• Total Current Liabilities rose to $174.3 million in Q4 2025 per CRMD's latest filing, from $133.6 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $174.3 million in Q4 2025 and troughed at $3.0 million in Q1 2021.
• A 5-year average of $25.8 million and a median of $7.5 million in 2023 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2021 and 2025: Total Current Liabilities slumped 47.46% in 2021, then surged 623.14% in 2025.
• Over 5 years, Total Current Liabilities stood at $5.3 million in 2021, then rose by 18.07% to $6.3 million in 2022, then jumped by 80.65% to $11.4 million in 2023, then soared by 196.83% to $33.8 million in 2024, then surged by 414.98% to $174.3 million in 2025.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $174.3 million, $133.6 million, and $31.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.